Tag: AKBA

  • Small Cap Bearish Stocks: Unilife Corp (NASDAQ:UNIS), bebe stores (NASDAQ:BEBE), Akebia Therapeutics Inc. (NASDAQ:AKBA), Castlight Health (NYSE:CSLT)

    Unilife Corp (NASDAQ:UNIS) announced that Dennis Pyers, Vice-President and Controller of Unilife since 2010, has been named Interim CFO. Pyers replaces Richard Wieland who is leaving Unilife after four years as Executive Vice President and CFO. Dennis P. Pyers, CPA, has served as the Chief Accounting Officer, Vice President and Controller of Unilife Corporation since July 2010. Unilife Corp (NASDAQ:UNIS) shares after opening at $3.58 moved to $3.65 on last trade day and at the end of the day closed at $3.19. Company price to sales ratio in past twelve months was calculated as 40.43 and price to cash ratio as 76.16. Unilife Corp (NASDAQ:UNIS) showed a negative weekly performance of -7.00%.

    Bebe Stores Inc. (NASDAQ:BEBE) lowered its third-quarter profit forecast on Tuesday, saying that store closures, extreme weather and holiday timing took a toll on its sales. bebe stores, Inc. (NASDAQ:BEBE) shares fell -9.94% in last trading session and ended the day on $5.80. BEBE return on equity ratio is recorded as -32.70% and its return on assets is -24.90%. bebe stores, Inc. (NASDAQ:BEBE) yearly performance is 33.33%.

    Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, on 15 April announced it has completed enrolment in its ongoing 200-patient Phase 2b study of AKB-6548 for the treatment of anemia associated with chronic kidney disease (CKD) in patients who are not dependent on dialysis. Akebia Therapeutics Inc. (NASDAQ:AKBA) shares moved down -5.73% in last trading session and was closed at $25.49, while trading in range of $23.80 – $27.85. Akebia Therapeutics Inc. (NASDAQ:AKBA) year to date (YTD) performance is -4.50%.

    Castlight Health, Inc. (NYSE:CSLT), a leading provider of enterprise healthcare cloud software, announced that it has scheduled a conference call to review its first quarter 2014 results (ended March 31, 2014) for Wednesday, May 7, 2014. Castlight Health Inc. (NYSE:CSLT) weekly performance is 3.33%. On last trading day company shares ended up $16.74. Castlight Health Inc. (NYSE:CSLT) distance from 50-day simple moving average (SMA50) is -30.12%. Analysts mean target price for the company is $24.25.